FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057436 [Registered on: 11/09/2023] Trial Registered Prospectively
Last Modified On: 18/09/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A randomized control trial of a brief educational intervention on colonoscopy preparation in inflammatory bowel disease 
Scientific Title of Study   A randomized control trial to assess the effectiveness of a brief educational intervention on colonoscopy preparation and experience in patients with inflammatory bowel disease  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vishal Sharma 
Designation  Associate Professor 
Affiliation  Postgraduate Institute of Medical Education and Research  
Address  Associate Professor Room No 12 Nehru Hospital F Block Department of Gastroenterology Postgraduate Institute of Medical Education and Research Sector 12
Sector 12
Chandigarh
CHANDIGARH
160012
India 
Phone  7087008099  
Fax    
Email  docvishalsharma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vishal Sharma 
Designation  Associate Professor 
Affiliation  Postgraduate Institute of Medical Education and research  
Address  Associate Professor Department of Gastroenterology Room No 12 Nehru Hospital F Block Postgraduate Institute of Medical Education and research Sector 12
Sector 12

CHANDIGARH
160012
India 
Phone  7087008099  
Fax    
Email  docvishalsharma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  SUMANPREET KAUR 
Designation  NURSING OFFICER 
Affiliation  Block Postgraduate Institute of Medical Education and research  
Address  Nursing Officer GEICU F BLOCK NEHRU HOSPITAL Block Postgraduate Institute of Medical Education and research SECTOR 12
Sector 12
Chandigarh
CHANDIGARH
160012
India 
Phone  6280945373  
Fax    
Email  sumanbrar466@gmail.com  
 
Source of Monetary or Material Support  
Postgraduate Institute of Medical Education and Research, Chandigarh  
 
Primary Sponsor  
Name  Postgraduate Institute of Medical Education and research  
Address  Director, Postgraduate Institute of Medical Education and Research, Chandigarh, India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vishal Sharma  Postgraduate Institute of Medical Education and research   Department of Gastroenterology, Nehru Hospital, Postgraduate Institute of Medical Education and research, Sector 12
Chandigarh
CHANDIGARH 
7087008099

docvishalsharma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Postgraduate Institute of Medical Education and Research, Chandigarh Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K50||Crohns disease [regional enteritis], (2) ICD-10 Condition: K51||Ulcerative colitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Brief educational intervention  Apart from the standard guidelines and preparation as done in comparator group, a brief video will be shown to the patient or one attendant in the language of their choice Hindi or Punjabi or English. The video will also be provided through WhatsApp or link to Youtube. The patient will be allowed to ask questions after the video. The video provides brief information about What is IBD, Why is colonoscopy needed in IBD, Why bowel preparation is needed for colonoscopy, What are the consequences of poor preparation, How to prepare for a colonoscopy, including diet and PEG preparation. The duration of this video is between 5-10 minutes (slight variation in time for the three languages) 
Comparator Agent  Standard Arm  The preparation for colonoscopy will be as per the standard ESGE guidelines. We will suggest a low fibre diet for two days preceding the start of bowel preparation. A standard split dose preparation will be used. Polyethylene glycol (PEG) will be used. A PEG sachet of 137.15 gram will be dissolved in 2 litres of water. On the day before the procedure the patient will be advised to take 2 litres over a three-hour period in the evening 5-8 PM. On the day of the procedure, another 2 litres of preparation would be administered in the morning from 4-6 AM. The procedure would be started between 10:30 AM to 12:30 PM on the day of the procedure. The procedure will be performed under conscious sedation which means that injection Midazolam 2mg will be given to the patients before the procedure. 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients with inflammatory bowel disease undergoing colonoscopy for mapping of disease extent or dysplasia screening
 
 
ExclusionCriteria 
Details  Contraindications for colonoscopy eg active disease precluding colonoscopy, acute obstruction
Suspected stricturing disease on previous imaging or clinical symptoms
Severe systemic illness- symptomatic heart failure, CTP -C cirrhosis, chronic kidney disease with GFR < 30
Unwilling to participate
Pregnant and breastfeeding females
Psychiatric co morbidities (clinical depression, bipolar disorder or schizophrenia)
Re procedure for a patient already randomized or already included in a trial
Patients undergone an abdominal surgery in the past related to bowel disease
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Adequate bowel preparation as defined using Boston bowel preparation score of 6 or more  baseline on day of colonoscopy  
 
Secondary Outcome  
Outcome  TimePoints 
Perfect bowel preparation as defined using Boston bowel preparation score of 9  Day Zero 
Worsening of disease activity as per increase in SCCAI or HBI score   14 days  
Tolerance of bowel preparation   Day zero 
Satisfaction with bowel preparation   Day zero 
Time to cecal intubation

 
zero day 
Anxiety as assessed by GAD-7 score  14 days 
Tolerance of procedure   14 days  
Willingness to undergo colonoscopy again if needed  14 days  
 
Target Sample Size   Total Sample Size="130"
Sample Size from India="130" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="130" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/09/2023 
Date of Study Completion (India) 19/08/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In this randomised trial, patients with inflammatory bowel disease who are planned for a colonoscopy for established indication will be randomized to either receive or not receive a brief video-based education intervention. All patients will receive a written document in the language of their choice to explain the colonoscopy and its need and preparation. However, half of the patients will randomly receive a video in English / Hindi/ Punjabi which provides explanation of the colonoscopy and need for adequate preparation. We will assess if those who receive an educational video intervention have a better colonoscopy preparation, and if their experience of the procedure is better than those who do not receive the educational intervention. The trial will not entail any additional costs, procedures, visits than are clinically indicated 
Close